SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435956. A total of 2 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $11,388,000 | +10.7% | 65,900 | -26.4% | 0.01% | +10.0% |
| Q4 2014 | $10,287,000 | -17.2% | 89,500 | +12.6% | 0.01% | -23.1% |
| Q3 2014 | $12,421,000 | +33.4% | 79,500 | +5.3% | 0.01% | +18.2% |
| Q2 2014 | $9,313,000 | +132.9% | 75,500 | +95.6% | 0.01% | +120.0% |
| Q1 2014 | $3,999,000 | +158.5% | 38,600 | +124.4% | 0.01% | +150.0% |
| Q4 2013 | $1,547,000 | +15.6% | 17,200 | -14.0% | 0.00% | 0.0% |
| Q3 2013 | $1,338,000 | +9.3% | 20,000 | +8.1% | 0.00% | 0.0% |
| Q2 2013 | $1,224,000 | – | 18,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 9,300 | $622,000 | 0.01% |
| Citadel Advisors | 20,000 | $1,338,000 | 0.00% |